China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
19.66
+0.29 (1.50%)
Sep 30, 2026, 3:04 PM CST

SHE:000028 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
72,88673,41674,37875,47773,44368,358
Revenue Growth
-0.69%-1.29%-1.46%2.77%7.44%14.60%
Gross Profit
7,5057,7978,1989,0068,8837,986
Operating Income
1,6531,7201,5562,4112,2982,031
Net Income
1,0761,136642.491,5991,4871,336
Earnings Per Share
1.751.851.052.612.432.18
EPS Growth
91.01%77.38%-59.93%7.49%11.25%-4.59%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Headquarters
7.71
Distribution
53,321
Retail
20,981
Offset of Business Segment
-893.99
Total
73,416

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,9337,8027,4096,5026,0165,126
Total Debt
3,5724,5075,7375,3744,3914,786
Net Cash (Debt)
2,3613,2951,6711,1291,626340.48
Net Cash Growth
8009.05%97.18%48.07%-30.58%377.51%-82.99%
Net Cash Per Share
3.855.382.721.842.660.56

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
104.81,6393,2712,9372,5601,655
Capital Expenditures
-162.36-217.35-282.7-322.21-322.19-370.43
Free Cash Flow
-57.561,4212,9892,6152,2381,285
Free Cash Flow Growth
--52.45%14.30%16.83%74.22%6.27%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
10.30%10.62%11.02%11.93%12.09%11.68%
Operating Margin
2.27%2.34%2.09%3.19%3.13%2.97%
Pretax Margin
1.95%2.06%0.77%3.28%3.15%2.89%
Profit Margin
1.48%1.55%0.86%2.12%2.02%1.96%
FCF Margin
-0.08%1.94%4.02%3.46%3.05%1.88%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.5600.5600.3330.6180.5590.420
Dividend Per Share Growth
85.14%68.32%-46.18%10.49%33.34%-24.99%
Dividend Yield
2.85%2.58%1.31%2.50%2.63%1.79%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.2011.2423.599.348.8511.00
Forward PE
10.4610.3616.4310.1010.1410.13
P/FCF Ratio
-8.995.075.715.8811.45
PS Ratio
0.160.170.200.200.180.22